Bayer, Abbott, J&J Billion-Dollar Tort Risk

Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode, BI litigation analysts Holly Froum and Matthew Schettenhelm are joined by mass tort expert Joseph Fantini to discuss some of the major hurdles facing companies, including weedkiller cancer claims against Bayer’s Monsanto, NEC litigation against Abbott and Reckitt’s Mead Johnson unit, talc litigation against Johnson & Johnson, social-media addiction lawsuits against Meta, Google and others, and more. They discuss potential catalysts on the horizon, the strength of cases and the likelihood of any global settlements.

See omnystudio.com/listener for privacy information.